5 assets in Bone Giant Cell Tumor

Therapeutic assets addressing Bone Giant Cell Tumor, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Cyclophosphamide Bone Giant Cell Tumor	M.D. Anderson Cancer Center	P2	CCC (53)
Fludarabine Bone Giant Cell Tumor	M.D. Anderson Cancer Center	P2	CCC (53)
Ipilimumab Bone Giant Cell Tumor	M.D. Anderson Cancer Center	P2	CCC (53)
Lifileucel Bone Giant Cell Tumor	M.D. Anderson Cancer Center	P2	CCC (53)
Nivolumab Bone Giant Cell Tumor	M.D. Anderson Cancer Center	P2	CCC (53)